Literature DB >> 7795059

Teicoplanin selects for Staphylococcus aureus that is resistant to vancomycin.

D M Shlaes, J H Shlaes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7795059     DOI： 10.1093/clinids/20.4.1071

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  11 in total

1.  Analysis of vancomycin population susceptibility profiles, killing activity, and postantibiotic effect against vancomycin-intermediate Staphylococcus aureus.

Authors:  J R Aeschlimann; E Hershberger; M J Rybak
Journal:  Antimicrob Agents Chemother       Date:  1999-08       Impact factor: 5.191

2.  Decreased susceptibilities to teicoplanin and vancomycin among coagulase-negative methicillin-resistant clinical isolates of staphylococci.

Authors:  K Sieradzki; P Villari; A Tomasz
Journal:  Antimicrob Agents Chemother       Date:  1998-01       Impact factor: 5.191

3.  Activities of trovafloxacin and ampicillin-sulbactam alone or in combination versus three strains of vancomycin- intermediate Staphylococcus aureus in an in vitro pharmacodynamic infection model.

Authors:  J R Aeschlimann; E Hershberger; M J Rybak
Journal:  Antimicrob Agents Chemother       Date:  2000-05       Impact factor: 5.191

Review 4.  Methicillin-resistant staphylococci in clean surgery. Is there a role for prophylaxis?

Authors:  E Mini; S Nobili; P Periti
Journal:  Drugs       Date:  1997       Impact factor: 9.546

5.  Peptidoglycan synthesis and structure in Staphylococcus haemolyticus expressing increasing levels of resistance to glycopeptide antibiotics.

Authors:  D Billot-Klein; L Gutmann; D Bryant; D Bell; J Van Heijenoort; J Grewal; D M Shlaes
Journal:  J Bacteriol       Date:  1996-08       Impact factor: 3.490

6.  Activities of LY333328 and vancomycin administered alone or in combination with gentamicin against three strains of vancomycin-intermediate Staphylococcus aureus in an in vitro pharmacodynamic infection model.

Authors:  J R Aeschlimann; G P Allen; E Hershberger; M J Rybak
Journal:  Antimicrob Agents Chemother       Date:  2000-11       Impact factor: 5.191

7.  Heterogeneous vancomycin-intermediate susceptibility phenotype in bloodstream methicillin-resistant Staphylococcus aureus isolates from an international cohort of patients with infective endocarditis: prevalence, genotype, and clinical significance.

Authors:  In-Gyu Bae; Jerome J Federspiel; José M Miró; Christopher W Woods; Lawrence Park; Michael J Rybak; Thomas H Rude; Suzanne Bradley; Suzana Bukovski; Cristina Garcia de la Maria; Souha S Kanj; Tony M Korman; Francesc Marco; David R Murdoch; Patrick Plesiat; Marta Rodriguez-Creixems; Porl Reinbott; Lisa Steed; Pierre Tattevin; Marie-Françoise Tripodi; Karly L Newton; G Ralph Corey; Vance G Fowler
Journal:  J Infect Dis       Date:  2009-11-01       Impact factor: 5.226

8.  Increased oxacillin activity associated with glycopeptides in coagulase-negative staphylococci.

Authors:  B E Domaracki; A Evans; K E Preston; H Fraimow; R A Venezia
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-03       Impact factor: 3.267

9.  Mechanism of action of the mannopeptimycins, a novel class of glycopeptide antibiotics active against vancomycin-resistant gram-positive bacteria.

Authors:  Alexey Ruzin; Guy Singh; Anatoly Severin; Youjun Yang; Russell G Dushin; Alan G Sutherland; Albert Minnick; Michael Greenstein; Michael K May; David M Shlaes; Patricia A Bradford
Journal:  Antimicrob Agents Chemother       Date:  2004-03       Impact factor: 5.191

10.  Structural and functional characterization of methicillin-resistant Staphylococcus aureus's class IIb fructose 1,6-bisphosphate aldolase.

Authors:  Glenn C Capodagli; Stephen A Lee; Kyle J Boehm; Kristin M Brady; Scott D Pegan
Journal:  Biochemistry       Date:  2014-11-21       Impact factor: 3.162
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.